HEADER ISOMERASE/IMMUNOSUPPRESSANT 01-MAR-10 2X7K TITLE THE CRYSTAL STRUCTURE OF PPIL1 IN COMPLEX WITH CYCLOSPORINE A SUGGESTS TITLE 2 A BINDING MODE FOR SKIP COMPND MOL_ID: 1; COMPND 2 MOLECULE: PEPTIDYL-PROLYL CIS-TRANS ISOMERASE-LIKE 1; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: PPIASE, ROTAMASE, PPIL1; COMPND 5 EC: 5.2.1.8; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: CYCLOSPORIN A; COMPND 9 CHAIN: B; COMPND 10 SYNONYM: CICLOSPORIN, CICLOSPORINE; COMPND 11 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: ROSETTA2; SOURCE 8 EXPRESSION_SYSTEM_VARIANT: DE3; SOURCE 9 EXPRESSION_SYSTEM_VECTOR: PGEX-6-P1; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PGEX-6-P1-PPIL1; SOURCE 11 MOL_ID: 2; SOURCE 12 SYNTHETIC: YES; SOURCE 13 ORGANISM_SCIENTIFIC: TOLYPOCLADIUM INFLATUM; SOURCE 14 ORGANISM_TAXID: 29910 KEYWDS ISOMERASE-IMMUNOSUPPRESSANT COMPLEX, ISOMERASE-CYCLOSPORIN COMPLEX, KEYWDS 2 CYCLOSPORIN A, IMMUNOSUPPRESSANT EXPDTA X-RAY DIFFRACTION AUTHOR C.M.STEGMANN,R.LUEHRMANN,M.C.WAHL REVDAT 7 16-OCT-19 2X7K 1 REMARK REVDAT 6 08-MAY-19 2X7K 1 REMARK LINK REVDAT 5 13-JUL-11 2X7K 1 VERSN REVDAT 4 21-APR-10 2X7K 1 JRNL REVDAT 3 14-APR-10 2X7K 1 SOURCE HETATM ANISOU REVDAT 2 07-APR-10 2X7K 1 TITLE JRNL REVDAT 1 23-MAR-10 2X7K 0 JRNL AUTH C.M.STEGMANN,R.LUEHRMANN,M.C.WAHL JRNL TITL THE CRYSTAL STRUCTURE OF PPIL1 BOUND TO CYCLOSPORINE A JRNL TITL 2 SUGGESTS A BINDING MODE FOR A LINEAR EPITOPE OF THE SKIP JRNL TITL 3 PROTEIN. JRNL REF PLOS ONE V. 5 13 2010 JRNL REFN ESSN 1932-6203 JRNL PMID 20368803 JRNL DOI 10.1371/JOURNAL.PONE.0010013 REMARK 2 REMARK 2 RESOLUTION. 1.15 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.15 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 34.28 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 2.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 61160 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.129 REMARK 3 R VALUE (WORKING SET) : 0.128 REMARK 3 FREE R VALUE : 0.149 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 3093 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 34.2925 - 3.2203 1.00 2867 143 0.1574 0.1647 REMARK 3 2 3.2203 - 2.5563 1.00 2724 143 0.1465 0.1575 REMARK 3 3 2.5563 - 2.2332 1.00 2690 127 0.1230 0.1476 REMARK 3 4 2.2332 - 2.0291 1.00 2691 156 0.1083 0.1345 REMARK 3 5 2.0291 - 1.8836 1.00 2626 150 0.1081 0.1146 REMARK 3 6 1.8836 - 1.7726 1.00 2637 157 0.1061 0.1299 REMARK 3 7 1.7726 - 1.6838 1.00 2648 157 0.1042 0.1271 REMARK 3 8 1.6838 - 1.6105 1.00 2633 134 0.1003 0.1391 REMARK 3 9 1.6105 - 1.5485 1.00 2641 128 0.0990 0.1214 REMARK 3 10 1.5485 - 1.4951 1.00 2605 142 0.0988 0.1433 REMARK 3 11 1.4951 - 1.4483 1.00 2631 158 0.1042 0.1262 REMARK 3 12 1.4483 - 1.4069 1.00 2614 137 0.1061 0.1265 REMARK 3 13 1.4069 - 1.3699 1.00 2622 135 0.1121 0.1318 REMARK 3 14 1.3699 - 1.3365 1.00 2627 153 0.1148 0.1462 REMARK 3 15 1.3365 - 1.3061 1.00 2603 121 0.1247 0.1617 REMARK 3 16 1.3061 - 1.2783 1.00 2634 119 0.1304 0.1642 REMARK 3 17 1.2783 - 1.2527 1.00 2622 140 0.1297 0.1637 REMARK 3 18 1.2527 - 1.2291 1.00 2571 133 0.1346 0.1633 REMARK 3 19 1.2291 - 1.2071 1.00 2630 135 0.1489 0.1797 REMARK 3 20 1.2071 - 1.1867 1.00 2558 148 0.1603 0.1962 REMARK 3 21 1.1867 - 1.1675 1.00 2665 125 0.1651 0.1944 REMARK 3 22 1.1675 - 1.1496 0.99 2528 152 0.1695 0.2126 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : 0.39 REMARK 3 B_SOL : 40.02 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.090 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 11.400 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 8.13 REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.57490 REMARK 3 B22 (A**2) : 0.96310 REMARK 3 B33 (A**2) : -2.53800 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.009 1455 REMARK 3 ANGLE : 2.205 1987 REMARK 3 CHIRALITY : 0.074 200 REMARK 3 PLANARITY : 0.007 264 REMARK 3 DIHEDRAL : 17.997 583 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2X7K COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 01-MAR-10. REMARK 100 THE DEPOSITION ID IS D_1290043050. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 21-APR-09 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.2 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : BESSY REMARK 200 BEAMLINE : 14.2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9 REMARK 200 MONOCHROMATOR : SI(111) REMARK 200 OPTICS : DOUBLE CRYSTAL MONOCHROMATOR REMARK 200 WITH 2 SETS OF MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 225 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 62933 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.150 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : 6.700 REMARK 200 R MERGE (I) : 0.08600 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 8.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.15 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.25 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.4 REMARK 200 DATA REDUNDANCY IN SHELL : 6.10 REMARK 200 R MERGE FOR SHELL (I) : 0.44000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: SAD REMARK 200 SOFTWARE USED: SHELXD REMARK 200 STARTING MODEL: NONE REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.32 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M HEPES, PH 7.2, 0.7 M SODIUM REMARK 280 ACETATE, 15 MM CDCL2 AND 50 MM GUANIDINE-HCL GROWN AT 4DEGC, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 51.60900 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 17.85050 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 51.60900 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 17.85050 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1250 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 8100 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -21.6 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A2063 LIES ON A SPECIAL POSITION. REMARK 375 HOH A2163 LIES ON A SPECIAL POSITION. REMARK 375 HOH A2169 LIES ON A SPECIAL POSITION. REMARK 400 REMARK 400 COMPOUND REMARK 400 CYCLOSPORIN IS A CYCLIC UNDECAPEPTIDE. REMARK 400 HERE, CYCLOSPORIN A IS REPRESENTED BY THE SEQUENCE (SEQRES) REMARK 400 REMARK 400 GROUP: 1 REMARK 400 NAME: CYCLOSPORIN A REMARK 400 CHAIN: B REMARK 400 COMPONENT_1: PEPTIDE LIKE SEQUENCE RESIDUES 1 TO 11 REMARK 400 DESCRIPTION: CYCLOSPORIN IS A CYCLIC UNDECAPEPTIDE. REMARK 400 CYCLIZATION IS ACHIEVED BY LINKING THE N- AND REMARK 400 THE C- TERMINI. REMARK 400 REMARK 400 THE CYCLOSPORIN A IS CYCLIC PEPTIDE, A MEMBER OF IMMUNOSUPPRESSANT REMARK 400 CLASS. REMARK 400 REMARK 400 GROUP: 1 REMARK 400 NAME: CYCLOSPORIN A REMARK 400 CHAIN: B REMARK 400 COMPONENT_1: PEPTIDE LIKE POLYMER REMARK 400 DESCRIPTION: CYCLOSPORIN IS A CYCLIC UNDECAPEPTIDE. CYCLIZATION REMARK 400 IS ACHIEVED BY LINKING THE N- AND THE C- TERMINI. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 ALA A 2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 C ABA B 6 H SAR B 7 0.66 REMARK 500 O HOH A 2209 O HOH A 2210 1.96 REMARK 500 O HOH A 2050 O HOH A 2051 2.02 REMARK 500 O ALA A 3 O HOH A 2001 2.06 REMARK 500 O HOH A 2209 O HOH A 2213 2.06 REMARK 500 O HOH A 2002 O HOH A 2003 2.11 REMARK 500 O HOH A 2165 O HOH A 2172 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH A 2010 O HOH A 2010 2555 1.98 REMARK 500 O HOH A 2002 O HOH A 2010 2555 2.01 REMARK 500 O HOH A 2051 O HOH A 2236 1565 2.13 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 MVA B 4 C BMT B 5 N 0.145 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP A 89 CB - CG - OD1 ANGL. DEV. = 6.0 DEGREES REMARK 500 MVA B 4 O - C - N ANGL. DEV. = -10.0 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ILE A 4 137.48 55.73 REMARK 500 ILE A 4 133.72 63.56 REMARK 500 PHE A 60 -81.43 -126.74 REMARK 500 THR A 119 56.67 -142.14 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A2047 DISTANCE = 5.94 ANGSTROMS REMARK 525 HOH A2103 DISTANCE = 6.33 ANGSTROMS REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CD A1167 CD REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CYS A 133 SG REMARK 620 2 ASP A 89 OD1 114.2 REMARK 620 3 ASP A 89 OD2 103.3 54.5 REMARK 620 4 HOH A2190 O 103.1 136.2 96.1 REMARK 620 5 HIS A 31 NE2 98.5 97.6 149.8 98.9 REMARK 620 6 HOH A2087 O 156.7 88.5 84.9 53.9 83.1 REMARK 620 N 1 2 3 4 5 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CD A1168 CD REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HOH A2239 O REMARK 620 2 HIS A 87 ND1 93.3 REMARK 620 3 CYS A 133 SG 109.9 112.3 REMARK 620 4 GLU A 26 OE2 141.6 104.7 94.3 REMARK 620 5 GLU A 26 OE1 94.5 136.0 105.4 49.4 REMARK 620 N 1 2 3 4 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 NA A1169 NA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HOH A2267 O REMARK 620 2 ASP A 7 OD1 148.5 REMARK 620 3 ASP A 7 OD2 106.4 48.3 REMARK 620 N 1 2 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CD A 1167 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CD A 1168 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NA A 1169 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN B OF CYCLOSPORIN A REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1BCK RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH CYCLOSPORIN REMARK 900 C REMARK 900 RELATED ID: 1C5F RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE CYCLOPHILIN-LIKE DOMAIN FROM BRUGIA MALAYI REMARK 900 COMPLEXED WITH CYCLOSPORIN A REMARK 900 RELATED ID: 1CSA RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF E.COLI CYCLOPHILIN (F112W) COMPLEXED WITH REMARK 900 CYCLOSPORIN A REMARK 900 RELATED ID: 1CWA RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH CYCLOSPORIN REMARK 900 A REMARK 900 RELATED ID: 1CWB RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH MODIFIED REMARK 900 CYCLOSPORIN A AT POSITION 5 REMARK 900 RELATED ID: 1CWC RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH MODIFIED REMARK 900 CYCLOSPORIN A AT POSITION 8 REMARK 900 RELATED ID: 1CWF RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH CYCLOSPORIN REMARK 900 D REMARK 900 RELATED ID: 1CWH RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH CYCLOSPORIN REMARK 900 A MODIFIED AT POSITION 7 REMARK 900 RELATED ID: 1CWI RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH MODIFIED REMARK 900 CYCLOSPORIN D AT POSITION 7 REMARK 900 RELATED ID: 1CWJ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH MODIFIED REMARK 900 CYCLOSPORIN D AT POSITIONS 5 AND 7. REMARK 900 RELATED ID: 1CWK RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH MODIFIED REMARK 900 CYCLOSPORIN D AT POSITIONS 5 AND 7. REMARK 900 RELATED ID: 1CWL RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH MODIFIED REMARK 900 CYCLOSPORIN A AT POSITION 8 REMARK 900 RELATED ID: 1CWM RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH MODIFIED REMARK 900 CYCLOSPORIN A AT POSITION 8 REMARK 900 RELATED ID: 1CWO RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH NODIFIED REMARK 900 CYCLOSPORIN C AT POSITIONS 1, AND 9 REMARK 900 RELATED ID: 1CYA RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF HUMAN CYCLOPHILIN COMPLEXED WIYH CYCLOSPORIN A REMARK 900 RELATED ID: 1CYB RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF HUMAN CYCLOPHILIN COMPLEXED WITH CYCLOSPORIN A REMARK 900 RELATED ID: 1CYN RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN B COMPLEXED WITH MODIFIED REMARK 900 CYCLOSPORIN A REMARK 900 RELATED ID: 1IKF RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CTCLOSPORIN-FAB COMPLEX REMARK 900 RELATED ID: 1M63 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CALCINEURIN-CYCLOPHILIN-CYCLOSPORIN COMPLEX REMARK 900 RELATED ID: 1MF8 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CALCINEURIN COMPLEXED WITH HUMAN REMARK 900 CYCLOPHILIN AND CYCLOSPORIN A REMARK 900 RELATED ID: 1MIK RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH MODIFIED REMARK 900 CYCLOSPORIN A AT POSITION 6 REMARK 900 RELATED ID: 1QNG RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF PLASMODIUM FALCIPARUM CYCLOPHILIN COMPLEXED REMARK 900 WITH CYCLOSPORIN A REMARK 900 RELATED ID: 1QNH RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF PLASMODIUM FALCIPARUM CYCLOPHILIN (DOUBLE REMARK 900 MUTANT) COMPLEXED WITH CYCLOSPORIN A REMARK 900 RELATED ID: 1XQ7 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI CYCLOPHILIN COMPLEXED WITH REMARK 900 CYCLOSPORIN A REMARK 900 RELATED ID: 2ESL RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN C COMPLEXED WITH CYCLOSPORIN REMARK 900 A REMARK 900 RELATED ID: 2OJU RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN J COMPLEXED WITH CYCLOSPORIN REMARK 900 A REMARK 900 RELATED ID: 2POY RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CRYPTOSPORIDIUM PARVUM IOWA II CYCLOPHILIN A REMARK 900 COMPLEXED WITH CYCLOSPORIN A REMARK 900 RELATED ID: 2RMA RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH CYCLOSPORIN REMARK 900 A REMARK 900 RELATED ID: 2RMB RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH MODIFIED REMARK 900 CYCLOSPORIN A AT POSITION 5 REMARK 900 RELATED ID: 2RMC RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF MURINE CYCLOPHILIN C COMPLEXED WITH REMARK 900 CYCLOSPORIN A REMARK 900 RELATED ID: 2WFJ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE PPIASE DOMAIN OF HUMAN CYCLOPHILIN G REMARK 900 COMPLEXED WITH CYCLOSPORIN A REMARK 900 RELATED ID: 2X2C RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN ACETYL-CYPA COMPLEXED WITH CYCLOSPORINE A REMARK 900 RELATED ID: 2Z6W RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN D IN COMPLEX WITH REMARK 900 CYCLOSPORIN A REMARK 900 RELATED ID: 3BO7 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CYCLOSPHILIN A FROM TOXOPLASMA GONDII REMARK 900 COMPLEXED WIT CYCLOSPORIN A REMARK 900 RELATED ID: 3CYS RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF THE HUMAN CYCLOSPORIN A COMPLEXED WITH REMARK 900 CYCLOSPORIN A REMARK 900 RELATED ID: 3EOV RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CYCLOPHILIN FROM LEISHMANIA DONOVANI COMPLEXED REMARK 900 WITH CYCLOSPORIN A REMARK 900 RELATED ID: 1XWN RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF CYCLOPHILIN LIKE 1(PPIL1) AND INSIGHTS INTO REMARK 900 ITS INTERACTION WITH SKIP DBREF 2X7K A 1 166 UNP Q9Y3C6 PPIL1_HUMAN 1 166 DBREF 2X7K B 1 11 NOR NOR00033 NOR00033 1 11 SEQRES 1 A 166 MET ALA ALA ILE PRO PRO ASP SER TRP GLN PRO PRO ASN SEQRES 2 A 166 VAL TYR LEU GLU THR SER MET GLY ILE ILE VAL LEU GLU SEQRES 3 A 166 LEU TYR TRP LYS HIS ALA PRO LYS THR CYS LYS ASN PHE SEQRES 4 A 166 ALA GLU LEU ALA ARG ARG GLY TYR TYR ASN GLY THR LYS SEQRES 5 A 166 PHE HIS ARG ILE ILE LYS ASP PHE MET ILE GLN GLY GLY SEQRES 6 A 166 ASP PRO THR GLY THR GLY ARG GLY GLY ALA SER ILE TYR SEQRES 7 A 166 GLY LYS GLN PHE GLU ASP GLU LEU HIS PRO ASP LEU LYS SEQRES 8 A 166 PHE THR GLY ALA GLY ILE LEU ALA MET ALA ASN ALA GLY SEQRES 9 A 166 PRO ASP THR ASN GLY SER GLN PHE PHE VAL THR LEU ALA SEQRES 10 A 166 PRO THR GLN TRP LEU ASP GLY LYS HIS THR ILE PHE GLY SEQRES 11 A 166 ARG VAL CYS GLN GLY ILE GLY MET VAL ASN ARG VAL GLY SEQRES 12 A 166 MET VAL GLU THR ASN SER GLN ASP ARG PRO VAL ASP ASP SEQRES 13 A 166 VAL LYS ILE ILE LYS ALA TYR PRO SER GLY SEQRES 1 B 11 DAL MLE MLE MVA BMT ABA SAR MLE VAL MLE ALA MODRES 2X7K MLE B 2 LEU N-METHYLLEUCINE MODRES 2X7K MLE B 3 LEU N-METHYLLEUCINE MODRES 2X7K MVA B 4 VAL N-METHYLVALINE MODRES 2X7K BMT B 5 THR MODRES 2X7K ABA B 6 ALA ALPHA-AMINOBUTYRIC ACID MODRES 2X7K SAR B 7 GLY SARCOSINE MODRES 2X7K MLE B 8 LEU N-METHYLLEUCINE MODRES 2X7K MLE B 10 LEU N-METHYLLEUCINE HET DAL B 1 5 HET MLE B 2 22 HET MLE B 3 22 HET MVA B 4 19 HET BMT B 5 30 HET ABA B 6 12 HET SAR B 7 11 HET MLE B 8 22 HET MLE B 10 22 HET CD A1167 1 HET CD A1168 1 HET NA A1169 1 HETNAM DAL D-ALANINE HETNAM MLE N-METHYLLEUCINE HETNAM MVA N-METHYLVALINE HETNAM BMT 4-METHYL-4-[(E)-2-BUTENYL]-4,N-METHYL-THREONINE HETNAM ABA ALPHA-AMINOBUTYRIC ACID HETNAM SAR SARCOSINE HETNAM CD CADMIUM ION HETNAM NA SODIUM ION FORMUL 2 DAL C3 H7 N O2 FORMUL 2 MLE 4(C7 H15 N O2) FORMUL 2 MVA C6 H13 N O2 FORMUL 2 BMT C10 H19 N O3 FORMUL 2 ABA C4 H9 N O2 FORMUL 2 SAR C3 H7 N O2 FORMUL 3 CD 2(CD 2+) FORMUL 5 NA NA 1+ FORMUL 6 HOH *294(H2 O) HELIX 1 1 ALA A 32 GLY A 46 1 15 HELIX 2 2 THR A 119 ASP A 123 5 5 HELIX 3 3 GLY A 135 GLY A 143 1 9 SHEET 1 AA 9 THR A 51 LYS A 52 0 SHEET 2 AA 9 LYS A 158 PRO A 164 -1 N ILE A 159 O THR A 51 SHEET 3 AA 9 ASN A 13 THR A 18 -1 O TYR A 15 N TYR A 163 SHEET 4 AA 9 GLY A 21 LEU A 27 -1 O GLY A 21 N THR A 18 SHEET 5 AA 9 ILE A 128 GLN A 134 -1 O ARG A 131 N GLU A 26 SHEET 6 AA 9 ILE A 97 MET A 100 -1 O LEU A 98 N PHE A 129 SHEET 7 AA 9 PHE A 112 THR A 115 -1 O PHE A 113 N ALA A 99 SHEET 8 AA 9 MET A 61 GLY A 64 -1 O ILE A 62 N VAL A 114 SHEET 9 AA 9 ARG A 55 ILE A 57 -1 O ARG A 55 N GLN A 63 LINK CD CD A1167 SG CYS A 133 1555 3545 2.54 LINK CD CD A1167 OD1 ASP A 89 1555 1555 2.42 LINK CD CD A1167 OD2 ASP A 89 1555 1555 2.31 LINK CD CD A1167 O HOH A2190 1555 1555 2.43 LINK CD CD A1167 NE2 HIS A 31 1555 1555 2.30 LINK CD CD A1167 O HOH A2087 1555 1555 2.54 LINK CD CD A1168 O HOH A2239 1555 1555 2.48 LINK CD CD A1168 ND1 HIS A 87 1555 3555 2.21 LINK CD CD A1168 SG CYS A 133 1555 1555 2.52 LINK CD CD A1168 OE2 GLU A 26 1555 1555 2.87 LINK CD CD A1168 OE1 GLU A 26 1555 1555 2.16 LINK NA NA A1169 O HOH A2267 1555 1554 2.86 LINK NA NA A1169 OD1 ASP A 7 1555 1555 2.90 LINK NA NA A1169 OD2 ASP A 7 1555 1555 2.41 LINK N DAL B 1 C ALA B 11 1555 1555 1.32 LINK C DAL B 1 N MLE B 2 1555 1555 1.34 LINK C MLE B 2 N MLE B 3 1555 1555 1.34 LINK C MLE B 3 N MVA B 4 1555 1555 1.35 LINK C MVA B 4 N BMT B 5 1555 1555 1.48 LINK C BMT B 5 N ABA B 6 1555 1555 1.34 LINK C ABA B 6 N SAR B 7 1555 1555 1.35 LINK C SAR B 7 N MLE B 8 1555 1555 1.33 LINK C MLE B 8 N VAL B 9 1555 1555 1.33 LINK C VAL B 9 N MLE B 10 1555 1555 1.33 LINK C MLE B 10 N ALA B 11 1555 1555 1.33 SITE 1 AC1 5 HIS A 31 ASP A 89 CYS A 133 HOH A2087 SITE 2 AC1 5 HOH A2190 SITE 1 AC2 4 GLU A 26 HIS A 87 CYS A 133 HOH A2239 SITE 1 AC3 2 ASP A 7 HOH A2267 SITE 1 AC4 25 GLU A 17 ARG A 55 PHE A 60 GLN A 63 SITE 2 AC4 25 GLY A 71 ALA A 101 ASN A 102 GLN A 111 SITE 3 AC4 25 PHE A 113 TRP A 121 HIS A 126 MET A 144 SITE 4 AC4 25 HOH A2032 HOH A2033 HOH A2066 HOH A2137 SITE 5 AC4 25 HOH A2161 HOH B2001 HOH B2002 HOH B2003 SITE 6 AC4 25 HOH B2004 HOH B2005 HOH B2006 HOH B2007 SITE 7 AC4 25 HOH B2008 CRYST1 103.218 35.701 45.851 90.00 90.00 90.00 P 21 21 2 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009688 0.000000 0.000000 0.00000 SCALE2 0.000000 0.028010 0.000000 0.00000 SCALE3 0.000000 0.000000 0.021810 0.00000